en

PRODUCT DETAIL

Lumeblue 25 mg tablety s predĺženým uvoľňovaním

Code 5515D
MA number EU/1/20/1470/001
Product Form: tbl plg 8x25 mg (blis.PA/Al/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 48 - DIAGNOSTICA
ATC:
V VARIOUS
V04 DIAGNOSTIC AGENTS
V04C OTHER DIAGNOSTIC AGENTS
V04CX Other diagnostic agents
Shelf life: 36
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 19.08.2020
Validity: 19.08.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 02.06.2021
eu-flag.png sk-flag.png